Keywords = SVR
| Number of Articles: 16 | ||||
| 1 | Biochemical study on the response to HCV therapy (Velpatasvir containing regimen), (vosevi) among adult patients’ non-responders to treatment in Fayoum Egypt | |||
| Volume 46, Issue 2, April 2023, Page 123-134 | ||||
| Hasnaa Sayed Kamal; Nancy Abdalla Atta; Naglaa Rifaat Ismael; Heba Ahmed Aldash; Ahmed Ali Gomaa | ||||
| 2 | Assessment of Incidence of Hepatocellular Carcinoma among Hepatitis C Patients Who Achieved Sustained Virological Response with Direct Acting Antiviral Agents (DAAs) | |||
| Volume 91, Issue 1, April 2023, Page 5276-5283 | ||||
| Ibrahim M. Ibrahim; Mohammed Emam Farghaly; Ahmed Embaby; Dina Gamal Abdallah Abdelrahman; Mona Ahmed Abdelmaksoud | ||||
| 3 | Safety and Efficacy of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C in Population Aged 60 Years and Older in Upper Egypt | |||
| Volume 6, Issue 1, January 2023, Page 152-159 | ||||
| Ali A. Ghweil; Mohamed Farouk Hassan Alemem; Mahmoud Kamal Elsamman; Ibrahim GamalEldin Ibrahim Radwan; Shamardan Ezzeldin S. Bazeed | ||||
| 4 | Assessment of Hepatitis C management on glycemic control among Type 2 Diabetes Mellitus patients | |||
| Volume 65, Issue 7, July 2022, Page 525-532 | ||||
| Abdelrahman Hassanein; Moustafa Hassan Ragab; Hanan Amer; Dalia Elmosalami; Mohamed Abdelrahman; Thanaa Rabah; Ahmed AboulGhate; Hazem El-Hariri | ||||
| 5 | Pattern of Response to Sofosbuvir and Daclatasvir +/- Ribavirin Regimen in Chronic Hepatitis C Patients | |||
| Volume 87, Issue 1, April 2022, Page 2057-2063 | ||||
| Reem M. Abd El Hamed; Ghada M. Galal; Nagwa S. Ahmed; Mahmoud Saif Al-Islam | ||||
| 6 | Serum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients | |||
| Volume 60, Issue 1, January 2022, Page 73-84 | ||||
| Hiam Salem; Nadia Y. S. Morcos; Wahid Doss; Mohamed Makhlouf; Kamal El Atrebi; Eman Saleh | ||||
| 7 | Changes in Sustained Treatment Response in Relapsed Chronic Hepatitis C Egyptian Patients on Directly Acting Antiviral Agents with Increased Insulin Resistance | |||
| Volume 83, Issue 1, April 2021, Page 1056-1061 | ||||
| Inas Elkhedr Mohamed; Yasser Omar Abdel Rahman; Ramy Samir Ghait; Alaa Lotfy ElSayed | ||||
| 8 | Outcome of Decompensated Hepatitis C Virus Cirrhotic Patients Treated with Direct Acting Antiviral Drugs | |||
| Volume 27, Issue 1, January 2021, Page 70-80 | ||||
| Amir Ahmed; Sahar Gouda Zagloul; Hoda Abdel-aziz El-hady; Ahmed Fathy Gomaa | ||||
| 9 | Effect of Treating Chronic Hepatitis C Infection with Direct-Acting Antivirals on The Risk of Recurrence Hepatocellular Carcinoma | |||
| Volume 79, Issue 1, April 2020, Page 362-368 | ||||
| 10 | PM2.5 Concentration Prediction for Air Pollution using Machine Learning Algorithms | |||
| Volume 28, ICEEM2019-Special Issue, 2019, Page 349-354 | ||||
| Ahmed Samy Abd El Aziz Moursi; Marwa A. Shouman; Ezz El-din Hemdan; Nawal El-Fishawy | ||||
| 11 | Correlation between platelet count and outcome of chronic HCV patients treated with direct-acting antivirals | |||
| Volume 2, Issue 1, January 2019, Page 1-9 | ||||
| Hosam M. Mohamed; Shamardan E. S. Bazeed; Heba A. Osman; Hanan M. Fayed | ||||
| 12 | EVALUATION OF DIRECT ACTING ANTIVIRAL AGENTS IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION IN ALEXANDRIA | |||
| Volume 39, Issue 2, August 2018, Page 33-40 | ||||
| Marwa Fekry; Mona H. Hashish; Heba S. Selim; Mie A. Ragab | ||||
| 13 | Comparison between the effect of Two Regimens for Hepatitis C Treatment (Qurevo and Ribavirin) and (Sofosbuvir, Daclatsvir and Ribavirin) on Patients above and below the Age of 60 Years | |||
| Volume 72, Issue 10, July 2018, Page 5385-5390 | ||||
| Mahmoud Abd El Majeed Othman; Motaz Mohamed Saied Abd EL Mawjood; Mohamed Osama Aly Aly; Aya Ahmed Morsy El Ghamry | ||||
| 14 | Chronic Hepatitis C Treatment: A Systematic Review | |||
| Volume 67, Issue 1, April 2017, Page 305-313 | ||||
| Aishah Mohammed Alenezi; Abdulaziz Hassan Mohammed Al-Fakih; Sultan Mohammed Al-Afif; Abdulkarem Mohammed Al-Afif; Bashayer Abbas Habib | ||||
| 15 | Pegylated Interferon, Ribavirin, and Sofosbuvir Combination versus Pegylated Interferon, Ribavirin in the Management of Chronic Hepatitis C Egyptian Patients | |||
| Volume 1, Issue 1, January 2017, Page 25-33 | ||||
| Abdel-Hameed Ebid; Mohamed Mobarez; Mohamed Adel; Ramadan Ramadan | ||||
| 16 | The Role of Vitamin D during Therapy in Chronic Hepatitis C Virus Infection and Its Relation to CYP 27 B1-1260 Promoter Polymorphism | |||
| Volume 64, Issue 1, July 2016, Page 287-303 | ||||
| Saadia Farid; Laila Rashed; Samya Sweilam | ||||
| | ||||
View on SCiNiTO